The results showed that DPYSL5 overexpression leads to a significant induction of neurite length and branch points in LNCaP (Fig. 3c) as well in C42B and VCaP prostate cancer cells (Supplementary Fig. 3d, e) when compared to control (CTRL) cells. Here, DPYSL5 is linked to prostate cancer.